FDA Brief

Warning letters Biologics

FDA warning letter to

BioStem Life Sciences

Issued Jan 17, 2025Posted Feb 4, 2025Center for Biologics Evaluation and Research (CBER)

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps). We haven't summarized this letter yet. Read it on fda.gov.